Jacqueline L. Olin

640 total citations
36 papers, 468 citations indexed

About

Jacqueline L. Olin is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Infectious Diseases. According to data from OpenAlex, Jacqueline L. Olin has authored 36 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Infectious Diseases. Recurrent topics in Jacqueline L. Olin's work include Diabetes Management and Research (6 papers), HIV/AIDS drug development and treatment (5 papers) and Diabetes Treatment and Management (4 papers). Jacqueline L. Olin is often cited by papers focused on Diabetes Management and Research (6 papers), HIV/AIDS drug development and treatment (5 papers) and Diabetes Treatment and Management (4 papers). Jacqueline L. Olin collaborates with scholars based in United States and Singapore. Jacqueline L. Olin's co-authors include Carrie L. Griffiths, Linda M. Spooner, Olga M. Klibanov, Christian R. Dolder, Joseph L. Gugliotta, Lisa Smith, Phillip L. Thornton, Sabrina W. Cole, Alexandre Chan and Donald S. Nuzum and has published in prestigious journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Annals of Pharmacotherapy and American Journal of Health-System Pharmacy.

In The Last Decade

Jacqueline L. Olin

35 papers receiving 460 citations

Peers

Jacqueline L. Olin

ONCOL

EPIDE

PRM

EDM

Noémie Simon‐Tillaux France

Yin Ping Wong Malaysia

Olivier Montagne France

Soon Kyu Lee South Korea

Chiz-Tzung Chang Taiwan

Qingqing Cai China

Pinfang Huang China

Helen S. Pentikis United States

Noémie Simon‐Tillaux France

Jacqueline L. Olin

145 ×1.2

67 ×0.7

ONCOL

60 ×1.0

EPIDE

89 ×1.6

PRM

28 ×0.5

EDM

Citations per year, relative to Jacqueline L. Olin Jacqueline L. Olin (= 1×) peers Noémie Simon‐Tillaux

Countries citing papers authored by Jacqueline L. Olin

Since Specialization

Citations

This map shows the geographic impact of Jacqueline L. Olin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline L. Olin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline L. Olin more than expected).

Fields of papers citing papers by Jacqueline L. Olin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline L. Olin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline L. Olin. The network helps show where Jacqueline L. Olin may publish in the future.

Co-authorship network of co-authors of Jacqueline L. Olin

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline L. Olin. A scholar is included among the top collaborators of Jacqueline L. Olin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline L. Olin. Jacqueline L. Olin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roman, Danielle, et al.. (2018). ASHP-HOPA guidelines on the roles and responsibilities of the pharmacy technician in ambulatory oncology pharmacy. American Journal of Health-System Pharmacy. 75(17). 1304–1311. 1 indexed citations

Olin, Jacqueline L., et al.. (2017). Venetoclax: A novel B-cell lymphoma-2 inhibitor for chronic lymphocytic leukemia and other hematologic malignancies. Journal of Oncology Pharmacy Practice. 24(7). 517–524. 3 indexed citations

Olin, Jacqueline L., et al.. (2017). New Pharmacotherapies in Chronic Lymphocytic Leukemia.. PubMed. 42(2). 106–115. 1 indexed citations

Gonzalvo, Jasmine D., Dhiren Patel, & Jacqueline L. Olin. (2017). Concentrated Insulins: A Review and Recommendations.. PubMed. 34(Suppl 8). S38–S43. 4 indexed citations

Olin, Jacqueline L. & Sabrina W. Cole. (2015). Computer-based clinical simulation cases in oncology pharmacotherapy: Student perceptions from two campuses. Currents in Pharmacy Teaching and Learning. 7(2). 157–162. 7 indexed citations

Cole, Sabrina W., et al.. (2014). Pomalidomide for the management of refractory multiple myeloma. American Journal of Health-System Pharmacy. 71(17). 1443–1448. 3 indexed citations

Olin, Jacqueline L., et al.. (2014). Aromatase Inhibitors in Breast Cancer Prevention. Annals of Pharmacotherapy. 48(12). 1605–1610. 22 indexed citations

Spooner, Linda M. & Jacqueline L. Olin. (2012). Tesamorelin: A Growth Hormone-Releasing Factor Analogue for HIV-Associated Lipodystrophy. Annals of Pharmacotherapy. 46(2). 240–247. 18 indexed citations

Griffiths, Carrie L. & Jacqueline L. Olin. (2012). Triple Negative Breast Cancer: A Brief Review of its Characteristics and Treatment Options. Journal of Pharmacy Practice. 25(3). 319–323. 96 indexed citations

10.

Dolder, Christian R., et al.. (2012). Prospective Measurement of a Problem-Based Learning Course Sequence. American Journal of Pharmaceutical Education. 76(9). 179–179. 10 indexed citations

11.

Olin, Jacqueline L., et al.. (2011). A Module on Death and Dying to Develop Empathy in Student Pharmacists. American Journal of Pharmaceutical Education. 75(4). 71–71. 30 indexed citations

12.

Klibanov, Olga M., et al.. (2011). Telaprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(10). 951–974. 8 indexed citations

13.

Olin, Jacqueline L., et al.. (2011). 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: A therapeutic controversy. Journal of clinical lipidology. 5(6). 450–459. 30 indexed citations

14.

Love, Bryan L., et al.. (2009). Hypertriglyceridaemia-induced acute pancreatitis due to patient non-compliance. Journal of Clinical Pharmacy and Therapeutics. 34(3). 363–367. 4 indexed citations

15.

Dolder, Christian R., et al.. (2009). Formulary Forum: Fesoterodine for the Treatment of Overactive Bladder. Annals of Pharmacotherapy. 43(12). 1992–2000. 4 indexed citations

16.

Love, Bryan L., et al.. (2008). Etravirine: A non-nucleoside reverse transcriptase inhibitor for the treatment of resistant HIV-1 infection. 43(3). 3 indexed citations

17.

Spooner, Linda M., Jacqueline L. Olin, & Ronald J. DeBellis. (2007). Pharmacotherapy of High-Altitude Illness. American Journal of Lifestyle Medicine. 1(2). 129–141. 2 indexed citations

18.

Olin, Jacqueline L. & Linda M. Spooner. (2006). Amphotericin B–Associated Hyperbilirubinemia: Case Report and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(7). 1011–1017. 4 indexed citations

19.

Dobesh, Paul P., Sara D. Brouse, Daniel Johnson, et al.. (2004). Key Articles and Guidelines Relative to Treatment of Patients with Acute Coronary Syndromes. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(1). 105–144. 8 indexed citations

20.

Olin, Jacqueline L. & Joseph L. Gugliotta. (2003). Possible Valacyclovir-Related Neurotoxicity and Aseptic Meningitis. Annals of Pharmacotherapy. 37(12). 1814–1817. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact